BioXcel Therapeutics Inc. (BTAI)
NASDAQ: BTAI
· Real-Time Price · USD
2.70
-0.12 (-4.26%)
At close: Sep 26, 2025, 3:59 PM
2.74
1.48%
After-hours: Sep 26, 2025, 07:44 PM EDT
-4.26% (1D)
| Bid | 2.11 |
| Market Cap | 53.05M |
| Revenue (ttm) | 868K |
| Net Income (ttm) | -50.95M |
| EPS (ttm) | -11.9 |
| PE Ratio (ttm) | -0.23 |
| Forward PE | -0.85 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 2.72 |
| Volume | 1,290,921 |
| Avg. Volume (20D) | 9,737,930 |
| Open | 2.93 |
| Previous Close | 2.82 |
| Day's Range | 2.66 - 2.96 |
| 52-Week Range | 1.17 - 13.28 |
| Beta | 0.21 |
| Ex-Dividend Date | n/a |
About BTAI
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BTAI
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for BTAI stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsBioXcel Therapeutics Inc. is scheduled to release its earnings on
Nov 13, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+1.55%
BioXcel Therapeutics shares are trading higher aft...
Unlock content with
Pro Subscription
1 month ago
+3.47%
BioXcel Therapeutics shares are trading higher after the company announced it has achieved alignment with the FDA on its sNDA package to expand IGALMI.
